Treatment of mice with a ?friendly? bacteria, normally found in the soil, altered their behavior in a way similar to that produced by antidepressant drugs, reports research published in the latest issue of Neuroscience.
Scientists at Dana-Farber Cancer Institute have shown in a laboratory study that revving up a crucial set of muscle genes counteracts the damage caused by a form of muscular dystrophy.
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the NewYork-Presbyterian Hospital/Weill Cornell Medical Center – led New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.
If you are one of the 370,000 Americans who lack functioning kidneys, you are all too familiar with the exhausting procedure of kidney dialysis. Three or four times every week, you visit a special clinic and sit for four hours as your blood is removed, cleaned and returned to your body.
Many Alzheimer’s patients are dying earlier because of sedatives they are being prescribed, according to new groundbreaking research from the Alzheimer’s Research Trust.
Up to 10 percent of women newly diagnosed with cancer in one breast develop cancer in the opposite breast. Results of a major clinical trial show that magnetic resonance imaging (MRI) scans are highly effective tools for quickly identifying these opposite breast cancers, detecting diseased tissue that other screening methods missed.
Chromosomal microarray analysis, a two-year-old gene-chip technology used to look for potential genetic abnormalities in children, has proved to be remarkably sensitive in detecting abnormalities in individual chromosomes.
Two Rutgers College of Nursing faculty members are conducting a study to develop and test a targeted intervention to reduce symptoms and improve the quality of life of patients undergoing prostate cancer treatment.
Schering-Plough Corporation (NYSE: SGP) announced that prescription-strength MiraLAX? (polyethylene glycol 3350) is now available as an over-the-counter (OTC) treatment for occasional constipation.
A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.